Key result
Advanced chronic kidney disease was independently associated with a higher risk of in-hospital post-procedural bleeding in patients undergoing percutaneous coronary intervention (OR 1.07, 95% CI 1.03-1.11, P<0.001).
Why the study?
Post-PCI bleeding increases mortality and remains challenging in CKD, but patients with advanced chronic kidney disease (ACKD) are often excluded from trials.
Does advanced chronic kidney disease increase the risk of in-hospital post-PCI bleeding in patients over age 40 undergoing percutaneous coronary intervention?
Cohort (n=1,826,536)
Yes
Does advanced chronic kidney disease increase the risk of in-hospital post-PCI bleeding in patients over age 40 undergoing percutaneous coronary intervention?
Odds Ratio: 1.07 (95% CI 1.03–1.11)
Absolute Event Rate: 133.9% vs 104.4%
p-value: p=<0.001
Advanced chronic kidney disease is an independent risk factor for in-hospital bleeding following percutaneous coronary intervention, highlighting the need for careful bleeding risk mitigation in this vulnerable population.
May warrant enhanced bleeding precautions in advanced CKD during PCI; leaves open need for targeted strategies in prospective studies.
BACKGROUND: Advanced chronic kidney disease (ACKD) is common in patients undergoing percutaneous coronary intervention (PCI). Post-PCI bleeding has been shown to increase mortality and remains an important challenge in these patients. Previous studies have shown increased post-PCI bleeding in CKD patients but often ACKD patients are excluded from these trials. The goal of this study was to evaluate if patients undergoing PCI with advanced renal disease have higher bleeding complications. METHODS: We analyzed the National Inpatient Sample (NIS) database to compare the post-PCI bleeding rates for ACKD (CKD stage 3 and above) undergoing PCI between 2006 and 2011 to those without ACKD in patients over the age of 40. Specific ICD-9 CM codes were used to identify these patients. RESULTS: A total of 49,192 patients had post-PCI bleeding during the study period of which 3,675 (7.5%) had ACKD. Patients with ACKD were older (68.7±11.7 years). During the study period, there was a decline in post-PCI bleeding rates in both ACKD and control groups. Patients with ACKD have significantly higher post-PCI bleeding rates compared to the control group. For example, in 2006, 133.9 in patients with ACKD had bleeding vs. 104.4 per 100,000 in patients without ACKD (P<0.05). After multivariate adjustment for bassline comorbidities, ACKD remained independently associated with post-PCI bleeding risk (OR: 1.07, CI: 1.03-1.11, P<0.001). CONCLUSION: Despite the overall decline in post-PCI bleeding in patients undergoing PCI, ACKD remains independently associated with post-procedural bleeding.
No takes yet. Share an insight, caveat, or question.
Mohammad Reza Movahed (2024) conducted a cohort in Patients undergoing percutaneous coronary intervention (PCI) (n=1,826,536). Advanced chronic kidney disease (ACKD) vs. Patients without advanced chronic kidney disease was evaluated on In-hospital post-PCI bleeding (OR 1.07, 95% CI 1.03-1.11, p=<0.001). Advanced chronic kidney disease was independently associated with a higher risk of in-hospital post-procedural bleeding in patients undergoing percutaneous coronary intervention (OR 1.07, 95% CI 1.03-1.11, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: